MOS-MoH 730A Revision 2017 commodities indicators (45)

Search:

Indicator Groups:

All    MOH 730_Stock on Hand (SoH)Facility Score cardLogisticsNutrition Indicator ScorecardSafe DeliveryBNA_GroupWorkTB_SCDRR quantity required for resupplyHospital Administrative Malaria Early Warning Data (MEWs)Malaria Scorecard IndicatorsInpatientART servicesHIV care and treatment-MOH 711TB_SCDRR Ending BalanceFamily Planning AttendanceMOH 729 ARTKHIS Data AlignmentMOS-MoH 730A Revision 2017 commoditiesFamily PlanningImmunisationMalariaIP Ward LevelPMTCT_NASCOPHIV Care Global Indicators '17TB ServicesMOH731TB_Months of Stock (MoS)Integrated ScorecardHEI Cohort Analysis Child HealthPost Natal CarePopulationTB Case Finding Revision 2016MOH-729B Patient SummaryOut PatientScorecard IndicatorsCommunity UnitHTC-MOH 711TB_Stock on hand (SoH)IDSR IndicatorsImmunization LogisticsEssential Services IndicatorsAntenatalService WorkloadNutrition IndicatorsFamily Planning MethodsMOH731-2 PMTCTTB Case FIndingBNA Tracer IndicatorsOphthalmic ServicesTB_ FCDRR Ending BalanceFP Commodities Couple Year ProtectionHSSF Coverage and PerformanceDraft Kenya RMNCAH ScorecardFP Commodities DIspensedOutcome IndicatorsRMNCAH SCORECARDEAC OHI DEMalaria CommoditiesFP Commodities Ending BalanceNVIP ScorecardMDR IndicatorsHIV testsHospital AdministrativeTB_FCDRR quantity required for resupplyiHRIS Human Resources Indicators

MOS-MoH 730A Revision 2017 Adult preparations Abacavir/Lamivudine (ABC/3TC) 600mg/300mg FDCTablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Abacavir/Lamivudine (ABC/3TC) 600mg/300mg FDCTablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Abacavir/Lamivudine (ABC/3TC) 600mg/300mg FDCTablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Abacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparationsAbacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparationsAbacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Dolutegravir(DTG) 50mg tabs 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Dolutegravir(DTG) 50mg tabs 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Dolutegravir(DTG) 50mg tabs 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Efavirenz (EFV) 600mg Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Efavirenz (EFV) 600mg Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Efavirenz (EFV) 600mg Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Lamivudine (3TC) 150mg Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Lamivudine (3TC) 150mg Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Lamivudine (3TC) 150mg Tablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Lopinavir/ritonavir (LPV/r) 200/50mg Tablets 120s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Lopinavir/ritonavir (LPV/r) 200/50mg Tablets 120s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Lopinavir/ritonavir (LPV/r) 200/50mg Tablets 120s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Nevirapine (NVP) 200mg Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Nevirapine (NVP) 200mg Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Nevirapine (NVP) 200mg Tablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Raltegravir (RAL) 400mg Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Raltegravir (RAL) 400mg Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Raltegravir (RAL) 400mg Tablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Tenofovir (TDF) 300mg Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Tenofovir (TDF) 300mg Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Tenofovir (TDF) 300mg Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Abacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Abacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Abacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Tenofovir/Emtricitabine (TDF/FTC) FDC (300/200mg) Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Tenofovir/Emtricitabine (TDF/FTC) FDC (300/200mg) Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Tenofovir/Emtricitabine (TDF/FTC) FDC (300/200mg) Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Tenofovir/Lamivudine (TDF/3TC) FDC (300/300mg) Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Tenofovir/Lamivudine (TDF/3TC) FDC (300/300mg) Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Tenofovir/Lamivudine (TDF/3TC) FDC (300/300mg) Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/400mg) FDC Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations enofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/400mg) FDC Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations enofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/400mg) FDC Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Darunavir (DRV) 150mg Tablets 240s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Darunavir (DRV) 150mg Tablets 240s PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Darunavir (DRV) 150mg Tablets 240s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Darunavir (DRV) 75mg Tablets 480s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Darunavir (DRV) 75mg Tablets 480s PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Darunavir (DRV) 75mg Tablets 480s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Darunavir (DRV) susp 100mg/ml (200ml Bottles)

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparationsDarunavir (DRV) susp 100mg/ml (200ml Bottles) PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparationsDarunavir (DRV) susp 100mg/ml (200ml Bottles) QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/600mg) FDC Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/600mg) FDC Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/600mg) FDC Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Efavirenz (EFV) 200mg Tablets 90s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Efavirenz (EFV) 200mg Tablets 90s PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Efavirenz (EFV) 200mg Tablets 90s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Zidovudine (AZT) 300mg Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Zidovudine (AZT) 300mg Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Zidovudine (AZT) 300mg Tablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Zidovudine/Lamivudine (AZT/3TC) FDC (300/150mg) Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Zidovudine/Lamivudine (AZT/3TC) FDC (300/150mg) Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Zidovudine/Lamivudine (AZT/3TC) FDC (300/150mg) Tablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Efavirenz (EFV) 200mg Tablets 90s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparationsEfavirenz (EFV) 200mg Tablets 90sPHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Efavirenz (EFV) 200mg Tablets 90s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Etravirine (ETV) 100mg Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Etravirine (ETV) 100mg Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Etravirine (ETV) 100mg Tablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (300/150/200mg) Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (300/150/200mg) Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (300/150/200mg) Tablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Lamivudine (3TC) liquid 10mg/ml (240ml Bottles)

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Lamivudine (3TC) liquid 10mg/ml (240ml Bottles) PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Lamivudine (3TC) liquid 10mg/ml (240ml Bottles)QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Lopinavir/ritonavir (LPV/r) 100/25mg Tabs 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Lopinavir/ritonavir (LPV/r) 100/25mg Tabs 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Lopinavir/ritonavir (LPV/r) 100/25mg Tabs 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Ethambutol 400mg Tab (for Pack of 28 tabs) 28s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS Ethambutol 400mg Tab (for Pack of 28 tabs) 28s PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Ethambutol 400mg Tab (for Pack of 28 tabs) 28s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Isoniazid (H) 100mg Tablets 100s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS TB/ HIV DRUGS Isoniazid (H) 100mg Tablets 100s PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Isoniazid (H) 100mg Tablets 100s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Lopinavir/ritonavir (LPV/r) liquid 80/20mg/ml (60ml Bottles)

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Lopinavir/ritonavir (LPV/r) liquid 80/20mg/ml (60ml Bottles) PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Lopinavir/ritonavir (LPV/r) liquid 80/20mg/ml (60ml Bottles) QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Isoniazid (H) 10mg/ml (120ml Bottles) 120ml Bottle

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS Isoniazid (H) 10mg/ml (120ml Bottles) 120ml Bottle PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Isoniazid (H) 10mg/ml QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 100 tabs) 100s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 100 tabs) 100s PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 100 tabs) 100s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 672 tabs) 672s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 672 tabs) 672s PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 672 tabs) 672s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Nevirapine (NVP) Susp 10mg/ml (100 ml Bottles)

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Nevirapine (NVP) Susp 10mg/ml (100 ml Bottles) PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Nevirapine (NVP) Susp 10mg/ml (100 ml Bottles)QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Pyrazinamide 500mg Tab (for Pack of 28 tabs) 28s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS Pyrazinamide 500mg Tab (for Pack of 28 tabs) 28s PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Pyrazinamide 500mg Tab (for Pack of 28 tabs) 28s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Pyridoxine 25mg Tabs 100s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS Pyridoxine 25mg Tabs 100s PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Pyridoxine 25mg Tabs 100s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Pyridoxine 50mg Tablets 100s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS Pyridoxine 50mg Tablets 100s PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Pyridoxine 50mg Tablets 100s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Rifabutin 150mg Tab 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS Rifabutin 150mg Tab 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Rifabutin 150mg Tab 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Ritonavir liquid 80mg/ml (90ml Bottles)

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparationsRitonavir liquid 80mg/ml (90ml Bottles) PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Ritonavir liquid 80mg/ml (90ml Bottles) QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Zidovudine (AZT) liquid 10mg/ml (240ml Bottles)

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Zidovudine (AZT) liquid 10mg/ml (240ml Bottles) PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Zidovudine (AZT) liquid 10mg/ml (240ml Bottles)QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Zidovudine/Lamivudine (AZT/3TC) FDC (60/30mg) Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Zidovudine/Lamivudine (AZT/3TC) FDC (60/30mg) Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Zidovudine/Lamivudine (AZT/3TC) FDC (60/30mg) Tablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (60/30/50mg) Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (60/30/50mg) Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (60/30/50mg) Tablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Medicines for OIs Acyclovir 400mg Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Medicines for OIs Acyclovir 400mg Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Medicines for OIs Acyclovir 400mg Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Medicines for Ols Amphotericin B 50mg IV Injection 1vial

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Medicines for OIs Amphotericin B 50mg IV Injection 1vial PHYSICAL COUNT divided by MoH 730B Revision 2017 Medicines for OIs Amphotericin B 50mg IV Injection 1vial QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Medicines for OIs Cotrimoxazole 960mg Tablets 100s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Medicines for OIs Cotrimoxazole 960mg Tablets 100s PHYSICAL COUNT divided by MoH 730B Revision 2017 Medicines for OIs Cotrimoxazole 960mg Tablets 100s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Medicines for OIs Cotrimoxazole suspension 240mg/5ml 100ml bottle

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Medicines for OIs Cotrimoxazole suspension 240mg/5ml 100ml bottle PHYSICAL COUNT divided by MoH 730B Revision 2017 Medicines for OIs Cotrimoxazole suspension 240mg/5ml 100ml bottle QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Medicines for OIs Fluconazole 200mg Tablets 100s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Medicines for OIsFluconazole 200mg Tablets 100s PHYSICAL COUNT divided by MoH 730B Revision 2017 Medicines for OIs Fluconazole 200mg Tablets 100s QUANTITY ISSUED